Inhibition of CD95 ligand-mediated inflammation.
Seino
K
K
Department of Surgery, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan.
Tun
T
T
Ohshima
N
N
Hamada
H
H
Yoshino
K
K
Ikeda
S
S
Fukunaga
K
K
Taniguchi
H
H
Takada
Y
Y
Yuzawa
K
K
Otsuka
M
M
Todoroki
T
T
Fukao
K
K
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D002455:Cell Division / Q000187:drug effects / Q000276:immunology; D003921:Diabetes Mellitus, Experimental / Q000601:surgery*; D053222:Fas Ligand Protein; D005998:Glycine / Q000031:analogs & derivatives / Q000494:pharmacology; D006877:Hydroxamic Acids / Q000494:pharmacology; D007249:Inflammation / Q000517:prevention & control*; D016753:Interleukin-10 / Q000235:genetics / Q000276:immunology; D016381:Islets of Langerhans Transplantation / Q000276:immunology*; D008114:Liver Neoplasms, Experimental / Q000473:pathology*; D008297:Male; D008562:Membrane Glycoproteins / Q000276:immunology*; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D008811:Mice, Inbred DBA; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins / Q000276:immunology; D014162:Transfection; D014183:Transplantation, Heterologous / Q000276:immunology*; D014407:Tumor Cells, Cultured; D019014:fas Receptor / Q000235:genetics / Q000276:immunology
D000970:Antineoplastic Agents; D053222:Fas Ligand Protein; C505658:Fasl protein, mouse; C505662:Faslg protein, rat; D006877:Hydroxamic Acids; C107086:KB R7785; D008562:Membrane Glycoproteins; D011994:Recombinant Proteins; D019014:fas Receptor; D016753:Interleukin-10; D008666:Metalloendopeptidases; D005998:Glycine